Biosimilars have been on the market in Europe since 2007 but have had a larger impact on Amgen since 2019 as US exposure intensifies. Pressure on Prolia/Xgeva is coming in 2025. Amgen's pipeline had ...

LENSAR, Inc.'s ALLY Robotic Cataract Laser System has driven significant revenue and earnings growth. Read why LNSR stock is ...

A new economic paradigm points to the advantages of adding alternative investments to your portfolio for diversification and ...

Inspire Medical Systems (INSP) holds a #3 (Hold) at the moment and its Most Accurate Estimate comes in at $0.78 a share 25 days away from its upcoming earnings release on February 10, 2025.

Advantage plans must provide at least the same medical and hospital benefits as Original Medicare. An Advantage plan covers hernia surgery. The costs of hernia surgery may vary depending on ...

Boston Scientific acquires Bolt Medical for $443 million upfront, with up to $221 million contingent on regulatory milestones. Bolt IVL platform uses acoustic waves to treat calcified artery ...

The acquisition is part of Boston Scientific's strategy to enhance its cardiovascular product offerings with the addition of Bolt Medical's intravascular ... cash flows to cover interest payments ...

Plans to buy Bolt Medical, Inc., a developer of intravascular ... using complimentary technologies to improve its cardiovascular portfolio. Using minimally invasive techniques, IVL treatment ...